Singapore Scientists Make Groundbreaking Discoveries in Stomach Cancer Research
A team of researchers from Singapore has made a major breakthrough in understanding stomach cancer, one of the deadliest forms of cancer worldwide. By leveraging cutting-edge mapping technologies, they developed a comprehensive “atlas” of stomach tumors, unveiling previously hidden patterns in cancer cell behavior, evolution, and interactions with the surrounding environment. These findings hold the potential to revolutionize treatment approaches, making them more precise and reducing unwanted side effects.
Their study, recently published in Cancer Discovery, paves the way for personalized therapies tailored to the unique characteristics of each patient’s tumor, thereby improving treatment efficacy against gastric cancer.
Unlocking the Tumor Microenvironment: Key Insights
Utilizing advanced computational and experimental techniques, the researchers identified notable differences in the characteristics of cancer cells located at the tumor’s core versus those at its periphery. These findings provide valuable knowledge on how gastric cancer cells interact with their microenvironment to grow and spread.
The study, conducted by the Singapore Gastric Cancer Consortium in collaboration with experts from Duke-NUS Medical School, the National University Cancer Institute, Singapore (NCIS), and the National University of Singapore Yong Loo Lin School of Medicine, also shed light on the distinct evolutionary paths that tumor cells take. This has important implications for understanding the immune responses driving tumor growth and resistance to treatment.
The Global Burden of Gastric Cancer
Stomach cancer remains a significant health challenge, ranking as the fifth most prevalent cancer and the third leading cause of cancer-related deaths globally. Each year, over one million new cases are diagnosed, and approximately 770,000 people lose their lives to the disease. In Singapore, gastric cancer remains among the top 10 causes of cancer-related deaths, claiming around 300 lives annually.
A Technological Leap in Cancer Research
In one of the largest studies of its kind, the researchers employed cutting-edge geospatial and genomic technologies to analyze 226 gastric cancer samples from 121 patients at the National University Hospital and other institutions. By utilizing spatial transcriptomics, they examined over 2,000 tumor microregions and integrated these findings with single-cell RNA sequencing data from 150,000 individual cells. This powerful combination allowed them to construct a high-resolution map of gastric cancer tissue, offering unparalleled insights into tumor composition and progression.
Professor Patrick Tan, the study’s senior author from Duke-NUS Medical School, compared this technological advancement to upgrading from an outdated paper map to a modern GPS system for cancer research. He emphasized that the ability to pinpoint cancer cells, track their behavior, and understand their mechanisms of spread equips scientists with the tools needed to design more targeted and effective treatments.
Identifying Tumor Subregions and Evolutionary Pathways
The study uncovered two major subgroups of cancer cells within tumors, each with distinct interactions with surrounding immune cells and blood vessels.
-
Core Tumor Cells: These cells experienced low oxygen levels and were less likely to spread.
-
Peripheral Tumor Cells: Highly invasive, these cells exhibited molecular features that increased their likelihood of metastasis.
By closely examining how cancer cells interact with non-cancerous cells, the researchers identified transforming growth factor-beta (TGF-β) signaling as a key pathway driving tumor progression. This pathway plays a crucial role in cell growth, differentiation, and immune response regulation. Targeting TGF-β could help disrupt tumor-promoting conditions, potentially leading to more effective cancer therapies.
The study also mapped distinct evolutionary trajectories in gastric cancer, each associated with different patient prognoses. These findings could aid in identifying biomarkers for personalized therapy, enabling doctors to implement tailored treatment strategies based on an individual’s tumor profile.
Toward a Future of Personalized Gastric Cancer Treatment
Dr. Raghav Sundar, a senior author and former senior consultant at NCIS, emphasized the groundbreaking nature of the research, highlighting how the high-resolution mapping of stomach cancer tissue has provided an unprecedented view of the interactions between cancer cells and their microenvironment. This deep understanding will be critical in developing innovative, targeted therapies that can bypass local barriers within tumors and improve treatment efficacy.
With these insights, the researchers are now actively working on identifying new therapeutic targets and testing them in preclinical models. Their ultimate goal is to advance toward smarter, more personalized cancer treatments, marking a significant step in the fight against gastric cancer.
